FindTrial
Sign In

dexmedetomidine combined with target-controlled infusion of remifentanil for procedural sedation and analgesia in plastic surgery

dexmedetomidine combined with target-controlled infusion of remifentanil for procedural sedation and analgesia in plastic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-OOC-17012399
Enrollment
Unknown
Registered
2017-08-17
Start date
2017-09-01
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

procedural sedation and analgesia in plastic surgery

Interventions

Group 2:dexmedetomidine combined with hand-controlled infusion of remifentanil
Group 1:propofol combined with target-controlled infusion of remifentanil

Sponsors

Plastic Surgery Hospital, CAMS, PUMC
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Aged 18-59 years old, ASA 1-2, BMI 30 minutes, informed consent signed

Exclusion criteria

Exclusion criteria: BMI>=30kg/m2, overstress, history of cardiovascular disease, respiratory disease, neuropsychopathy, and endocrine system disease, liver and kidney disfunction, known or admitted alcohol or drug misuse, abnormality in airway, hearing, and intelligence, and those with communication difficulties, and those who refused to give informed consent

Design outcomes

Primary

MeasureTime frame
respiratory profiles;satisfaction of patient;postoperative nausea and vomiting;intraoperative recall;—

Secondary

MeasureTime frame
hemodynamic profiles;dosage of drugs;duration of operation;postoperative recovery;duration of anesthesia;—

Countries

China

Contacts

Public ContactYuhui Wang

Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences

wyhlywyhly@163.com+86 13601234954

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026